USE OF TRANSCRIPTION FACTOR NAK-1 OR GENES REGULATED BY TRANSCRIPTION FACTOR NAK-1 FOR THE DIAGNOSIS AND/OR THERAPY OF INFLAMMATORY AND MALIGNANT DISEASES

Details for Australian Patent Application No. 2002322140 (hide)

Owner INSTITUT FUR GEFASSBIOLOGIE UND TROMBOSEFORSCHUNG DER MEDIZINISCHEN FACULTAT DER UNIVERSITAT WIEN

Inventors BINDER, Bernd, R.; SCHMID, Johannes; BRUESS, Johannes; HUFNAGL, Peter; GRUBER, Florian

Pub. Number AU-A-2002322140

PCT Number PCT/AT02/00188

PCT Pub. Number WO2003/003017

Priority A 1004/01 27.06.01 AT

Filing date 27 June 2002

Wipo publication date 3 March 2003

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): A 1004/01 27.06.01 AT

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322140

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322141-Unit and method for supply of users with heat energy or chilling energy

2002322139-HEARING DEVICE